Octreotide scintigraphy
Updates to Article Attributes
An octreoscanOctreotide is a scinitigraphic study that scintigraphy uses 111In labelled-labelled octreotide which which is a somatostatin analog; it is also known as an OctreoscanTM, a brand name for 111In-labelled pentetreotide; pentetreotide is a DTPA-conjugated form of octreotide, originally manufactured by Mallinckrodt Nuclear Medicine LLC, which now forms part of Curium). It is particularly useful for assessment of neuroendocrine tumours.
Examples include:
- carcinoid tumour
-
paraganglioma
(s) - small cell lung cancer
- pituitary adenoma
- neuroblastoma
- medullary thyroid carcinoma
- pancreatic islet cell tumour
Certain non-neuroendocrine tumours can also show uptake in an octreoscan. Examples include:
Also, certain autoimmune or granulomatous diseases may also occasionally show octreotide uptake with octreotide.
-<p>An <strong>octreoscan</strong> is a scinitigraphic study that uses <strong><sup>111</sup>In labelled octreotide</strong> which is a somatostatin analog. It is particularly useful for assessment of <a href="/articles/neuroendocrine-tumours">neuroendocrine tumours</a>.</p><p>Examples include:</p><ul>- +<p><strong>Octreotide</strong><strong> scintigraphy</strong> uses <sup>111</sup>In-labelled octreotide which is a somatostatin analog; it is also known as an Octreoscan<sup>TM</sup>, a brand name for <sup>111</sup>In-labelled pentetreotide; pentetreotide is a DTPA-conjugated form of octreotide, originally manufactured by Mallinckrodt Nuclear Medicine LLC, which now forms part of Curium). It is particularly useful for assessment of <a href="/articles/neuroendocrine-tumours">neuroendocrine tumours</a>.</p><p>Examples include:</p><ul>
-<a href="/articles/paraganglioma-1">paraganglioma(s)</a><ul>- +<a href="/articles/paraganglioma-1">paraganglioma</a><ul>
-</ul><p>Also, certain autoimmune or granulomatous diseases may also occasionally show uptake with octreotide.</p>- +</ul><p>Also, certain autoimmune or granulomatous diseases may occasionally show octreotide uptake.</p>